KETDARINA CORP

CIK:0001594114|SEC Filings

Statements of Operations and Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Operating expenses
Legal fees	$ 68,161	$ 40,635	$ 74,451	$ 127,412
Audit and accounting fees	8,600	10,400	49,200	61,500
Consulting fees	19,015		150,001	44,141
General and administrative expense	2,810		3,798	10,199
Total operating expense	98,856	50,834	277,450	243,252
Loss from operations	(98,856)	(50,834)	(277,450)	(243,252)
Other income (expenses)
Other Income	104,168		104,168
Interest expense	(11,721)		(23,442)
Total other income(expenses)	92,447		80,726
Net loss	$ (6,139)	$ (50,834)	$ (196,724)	$ (243,252)
Net loss per common share – basic and diluted
Weighted average common shares outstanding – basic and diluted	75,000,000	75,000,000	75,000,000	75,000,000

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net loss	$ (196,724)	$ (243,252)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Stock based compensation	71,452
Changes in assets and liabilities
Increase in accruals and other payables	(40,775)	114,617
Increase in related party payables	6,191	128,635
Net cash used in operating activities	(159,856)
Proceeds from Convertible note
Payments on related party debt
Net cash used in financing activities
Net increase in cash and cash equivalents	(159,856)
Effect of foreign currency translation on cash and cash equivalents
Cash and cash equivalents–beginning of period	180,079
Cash and cash equivalents–end of period	20,223
Supplementary cash flow information:
Interest paid
Income taxes paid
Non-Cash Financing and Investing Activities:
Forgiveness of related party debt
Payment on related party debt
Common stock issuable in conjunction with Convertible Note

Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2022	Jun. 30, 2022
Current assets
Cash and cash equivalents	$ 20,223	$ 180,079
Total current assets	20,223	180,079
TOTAL ASSETS	20,223	180,079
Current liabilities
Accrued liabilities and other current liabilities	110,036	150,811
Related parties loan payable	234,573	228,382
Convertible note, net of discount	430,000	430,000
Common stock payable	195,379	123,926
Total current liabilities	969,987	933,119
TOTAL LIABILITIES	969,987	933,119
COMMITMENTS & CONTINGENCIES
STOCKHOLDERS’ DEFICIT
Common stock, no par value; 75,000,000 shares authorized, 75,000,000 shares issued and outstanding at December 31, 2022 and June 30, 2022	75,000	75,000
Additional paid-in capital	(15,115)	(15,115)
Accumulated deficit	(1,009,649)	(812,925)
TOTAL STOCKHOLDERS’ DEFICIT	(949,765)	(753,041)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 20,223	$ 180,079